Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Although there is evidence for the effectiveness of interventions for psychosis among ultra-high-risk (UHR) groups, health economic evaluations are lacking. This study aimed to determine the cost effectiveness and cost–utility of cognitive–behavioural therapy (CBT) to prevent first-episode psychosis. Method: The Dutch Early Detection and Intervention Evaluation study was a randomized controlled trial of 196 UHR patients with an 18-month follow-up. All participants were treated with routine care (RC) for non-psychotic disorders. The experimental group (n = 95) received add-on CBT to prevent first-episode psychosis. We report the intervention, medical and travel costs, as well as costs arising from loss of productivity. Treatment response was defined as psychosis-free survival and quality-adjusted life years (QALYs) gained. Results: In the cost-effectiveness analysis, the proportion of averted psychoses was significantly higher in the CBT condition (89.5%v.76.2%). CBT showed a 63.7% probability of being more cost effective, because it was less costly than RC by US$844 (£551) per prevented psychosis. In the cost–utility analysis, QALY health gains were slightly higher for CBT than for RC (0.60 v.0.57) and the CBT intervention had a 52.3% probability of being the superior treatment because, for equal or better QALY gains, the costs of CBT were lower than those of RC. Conclusions: Add-on preventive CBT for UHR resulted in a significant reduction in the incidence of first psychosis. QALY gains show little difference between the two conditions. The CBT intervention proved to be cost saving.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattick, R. P., & Clarke, J. C. (1998) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)10031-6 · Cited by 3,367 · cited 1×
“Social anxiety was measured with the Social Interaction Anxiety Scale (Mattick & Clarke, 1998) and quality of life with the Manchester Short Assessment of Quality of Life (Priebe et al. 1999).”
MethodThe Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Fusar-Poli, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1472 · Cited by 1,361
Application and Results of the Manchester Short Assessment of Quality of Life (Mansa)
Priebe, S., Huxley, P., Knight, S., & Evans, S. (1999) · International Journal of Social Psychiatry · doi:10.1177/002076409904500102 · Cited by 1,071 · cited 2×
“Application and results of the Manchester Short Assessment of Quality of Life (MANSA).”
MethodReliability and validity of a depression rating scale for schizophrenics
Addington, D., Addington, J., Maticka-Tyndale, E., & Joyce, J. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90003-n · Cited by 651
Ising, H. K., Veling, W., Loewy, R. L., Rietveld, M. W., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Nieman, D. H., Wunderink, L., Linszen, D. H., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs068 · Cited by 460
Self-citationEarly interventions to prevent psychosis: systematic review and meta-analysis
Stafford, M. R., Jackson, H., Mayo-Wilson, E., Morrison, A. P., & Kendall, T. (2013) · BMJ · doi:10.1136/bmj.f185 · Cited by 456 · cited 3×
“In line with recent meta-analytic evidence showing that preventing psychosis in UHR groups is a feasible option (Fusar-Poli et al. 2013; Hutton & Taylor, 2013; Stafford et al. 2013; van der Gaag et al. 2013b), the present study demonstrates that add-on CBT for UHR is clinically effective.”
Resultvan der Gaag, M., Smit, F., Bechdolf, A., French, P., Linszen, D. H., Yung, A. R., McGorry, P., & Cuijpers, P. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.004 · Cited by 384 · cited 4×
“The CBT intervention consisted of the more generic protocol by French & Morrison (2004) enriched with education on dopamine supersensitivity, the effects of dopaminergic supersensitivity on perception and reasoning, and a metacognitive awareness training (van der Gaag et al. 2013a).”
BackgroundMethodResultInfluentialSelf-citationYung, A. R., Nelson, B., Stanford, C., Simmons, M. B., Cosgrave, E. M., Killackey, E., Phillips, L. J., Bechdolf, A., Buckby, J., & McGorry, P. D. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.012 · Cited by 358
van der Gaag, M., Nieman, D. H., Rietdijk, J., Dragt, S., Ising, H. K., Klaassen, R. M. C., Koeter, M., Cuijpers, P., Wunderink, L., & Linszen, D. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs105 · Cited by 209 · cited 3×
“To that end, a trial-based (van der Gaag et al. 2012) cost-effectiveness analysis (CEA; with prevented onset of psychosis as outcome) and cost–utility analysis [CUA; with quality-adjusted life years (QALYs) as outcome] were conducted in the outpatient mental healthcare setting in the Netherlands,…”
BackgroundMethodInfluentialSelf-citation
Cited by
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Altering the course of schizophrenia: progress and perspectives
Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516
Le, L. K.-D., Esturas, A. C., Mihalopoulos, C., Chiotelis, O., Bucholc, J., Chatterton, M. L., & Engel, L. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003606 · Cited by 256
Mei, C., van der Gaag, M., Nelson, B., Smit, F., Yuen, H. P., Berger, M., Krcmar, M., French, P., Amminger, G. P., Bechdolf, A., et al. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102005 · Cited by 143
Self-citationEarly interventions in risk groups for schizophrenia: what are we waiting for?
Sommer, I. E., Bearden, C. E., van Dellen, E., Breetvelt, E. J., Duijff, S. N., Maijer, K., van Amelsvoort, T., de Haan, L., Gur, R. E., Arango, C., et al. (2016) · npj Schizophrenia · doi:10.1038/npjschz.2016.3 · Cited by 140
Metadata
- Authors
- Ising, H. K., Smit, F., Veling, W., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Savelsberg, N. S. P., Boonstra, N., Nieman, D. H., Linszen, D. H., Wunderink, L., & van der Gaag, M.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2014-10-21
- Volume
- 45
- Issue
- 7
- Pages
- 1435-1446
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2136737825
- Cited by
- 55
- References
- 12
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial. https://app.cochat.ai/papers/10.1017/s0033291714002530
- The paper
- Ising, H. K., Smit, F., Veling, W., Rietdijk, J., Dragt, S., Klaassen, R. M. C., Savelsberg, N. S. P., Boonstra, N., Nieman, D. H., Linszen, D. H., Wunderink, L., & van der Gaag, M. (2015). Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trial. Psychological Medicine. https://doi.org/10.1017/s0033291714002530
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.